Ultragenyx Pharmaceutical Inc. Arcturus Therapeutics Holdings Inc. (ARCT) insider trading activity

ARCT Quotes by TradingView

Ultragenyx Pharmaceutical Inc. is Director of Arcturus Therapeutics Holdings Inc.. Currently has a direct ownership of 1.4 Million shares of ARCT, which is worth approximately $26.2 Million. The most recent transaction as insider was on Aug 11, 2021, when has been sold 75,000 shares (Common Stock) at a price of $45.83 per share, resulting in proceeds of $3,437,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.4M
0% 3M change
0% 12M change
Total Value Held $26.2 Million

Ultragenyx Pharmaceutical Inc. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 11 2021
SELL
Open market or private sale
$3,437,250 $45.83 p/Share
75,000 Reduced 5.08%
1,400,000 Common Stock
Aug 10 2021
SELL
Open market or private sale
$40,193,999 $55.44 p/Share
725,000 Reduced 32.95%
1,475,000 Common Stock
Dec 09 2020
SELL
Open market or private sale
$33,975,043 $94.97 p/Share
357,745 Reduced 13.99%
2,200,000 Common Stock
Dec 08 2020
SELL
Open market or private sale
$46,675,593 $105.54 p/Share
442,255 Reduced 14.74%
2,557,745 Common Stock
UPI

Ultragenyx Pharmaceutical Inc.

Director
Novato, CA

Track Institutional and Insider Activities on ARCT

Follow Arcturus Therapeutics Holdings Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARCT shares.

Notify only if

Insider Trading

Get notified when an Arcturus Therapeutics Holdings Inc. insider buys or sells ARCT shares.

Notify only if

News

Receive news related to Arcturus Therapeutics Holdings Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARCT